Cargando…

TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes

We previously developed TANTIGEN, a comprehensive online database cataloging more than 1000 T cell epitopes and HLA ligands from 292 tumor antigens. In TANTIGEN 2.0, we significantly expanded coverage in both immune response targets (T cell epitopes and HLA ligands) and tumor antigens. It catalogs 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guanglan, Chitkushev, Lou, Olsen, Lars Rønn, Keskin, Derin B., Brusic, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045306/
https://www.ncbi.nlm.nih.gov/pubmed/33849445
http://dx.doi.org/10.1186/s12859-021-03962-7
_version_ 1783678657340899328
author Zhang, Guanglan
Chitkushev, Lou
Olsen, Lars Rønn
Keskin, Derin B.
Brusic, Vladimir
author_facet Zhang, Guanglan
Chitkushev, Lou
Olsen, Lars Rønn
Keskin, Derin B.
Brusic, Vladimir
author_sort Zhang, Guanglan
collection PubMed
description We previously developed TANTIGEN, a comprehensive online database cataloging more than 1000 T cell epitopes and HLA ligands from 292 tumor antigens. In TANTIGEN 2.0, we significantly expanded coverage in both immune response targets (T cell epitopes and HLA ligands) and tumor antigens. It catalogs 4,296 antigen variants from 403 unique tumor antigens and more than 1500 T cell epitopes and HLA ligands. We also included neoantigens, a class of tumor antigens generated through mutations resulting in new amino acid sequences in tumor antigens. TANTIGEN 2.0 contains validated TCR sequences specific for cognate T cell epitopes and tumor antigen gene/mRNA/protein expression information in major human cancers extracted by Human Pathology Atlas. TANTIGEN 2.0 is a rich data resource for tumor antigens and their associated epitopes and neoepitopes. It hosts a set of tailored data analytics tools tightly integrated with the data to form meaningful analysis workflows. It is freely available at http://projects.met-hilab.org/tadb.
format Online
Article
Text
id pubmed-8045306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80453062021-04-14 TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes Zhang, Guanglan Chitkushev, Lou Olsen, Lars Rønn Keskin, Derin B. Brusic, Vladimir BMC Bioinformatics Software We previously developed TANTIGEN, a comprehensive online database cataloging more than 1000 T cell epitopes and HLA ligands from 292 tumor antigens. In TANTIGEN 2.0, we significantly expanded coverage in both immune response targets (T cell epitopes and HLA ligands) and tumor antigens. It catalogs 4,296 antigen variants from 403 unique tumor antigens and more than 1500 T cell epitopes and HLA ligands. We also included neoantigens, a class of tumor antigens generated through mutations resulting in new amino acid sequences in tumor antigens. TANTIGEN 2.0 contains validated TCR sequences specific for cognate T cell epitopes and tumor antigen gene/mRNA/protein expression information in major human cancers extracted by Human Pathology Atlas. TANTIGEN 2.0 is a rich data resource for tumor antigens and their associated epitopes and neoepitopes. It hosts a set of tailored data analytics tools tightly integrated with the data to form meaningful analysis workflows. It is freely available at http://projects.met-hilab.org/tadb. BioMed Central 2021-04-14 /pmc/articles/PMC8045306/ /pubmed/33849445 http://dx.doi.org/10.1186/s12859-021-03962-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Software
Zhang, Guanglan
Chitkushev, Lou
Olsen, Lars Rønn
Keskin, Derin B.
Brusic, Vladimir
TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
title TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
title_full TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
title_fullStr TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
title_full_unstemmed TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
title_short TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
title_sort tantigen 2.0: a knowledge base of tumor t cell antigens and epitopes
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045306/
https://www.ncbi.nlm.nih.gov/pubmed/33849445
http://dx.doi.org/10.1186/s12859-021-03962-7
work_keys_str_mv AT zhangguanglan tantigen20aknowledgebaseoftumortcellantigensandepitopes
AT chitkushevlou tantigen20aknowledgebaseoftumortcellantigensandepitopes
AT olsenlarsrønn tantigen20aknowledgebaseoftumortcellantigensandepitopes
AT keskinderinb tantigen20aknowledgebaseoftumortcellantigensandepitopes
AT brusicvladimir tantigen20aknowledgebaseoftumortcellantigensandepitopes